Modulators of dopamine neurotransmission

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/20 (2006.01) A61K 31/357 (2006.01) A61P 25/00 (2006.01) C07D 311/58 (2006.01) C07D 319/16 (2006.01)

Patent

CA 2722978

The present invention relates to novel 1-(2,3-dihydro-1,4-benzodioxin-2-yl)- methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically as dopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

La présente invention concerne de nouveaux dérivés de la 1-(2,3-dihydro-1,4-benzodioxin-2-yl)-méthanamine, utiles en tant que modulateurs de la neurotransmission de la dopamine, et plus spécifiquement en tant que stabilisateurs dopaminergiques. Dans dautres aspects, linvention concerne lutilisation de ces composés dans un procédé thérapeutique et des compositions pharmaceutiques comprenant les composés de linvention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulators of dopamine neurotransmission does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of dopamine neurotransmission, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of dopamine neurotransmission will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2040406

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.